Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barry Kay

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skinSimon Phipps, Sun Ying, Arun Wangoo, et al.
American Journal of Respiratory Cell and Molecular Biology|August 31, 2004
Acute allergen-induced airway remodeling in atopic asthmaSimon Phipps, Farid Benyahia, Tsan-Teng Ou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteersAndrew Menzies-Gow, Sun Ying, Ian Sabroe, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2005
Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challengeYee Ean Ong, Andrew Menzies-Gow, Julia Barkans, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmaticsAndrew Menzies-Gow, Patrick Flood-Page, Roma Sehmi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 4, 2008
Eosinophils: biological properties and role in health and diseaseSimon P Hogan, Helene F Rosenberg, Redwan Moqbel, et al.
The Journal of Clinical Investigation|October 3, 2003
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsPatrick Flood-Page, Andrew Menzies-Gow, Simon Phipps, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthmaHarsha H Kariyawasam, Sophie Pegorier, Julia Barkans, et al.
Immunology|July 23, 2003
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammationRoma Sehmi, Sandra Dorman, Adrian Baatjes, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2011
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergyMargitta Worm, Hae-Hyuk Lee, Jörg Kleine-Tebbe, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|October 9, 2002
The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skinSimon Phipps, Sun Ying, Arun Wangoo, et al.
American Journal of Respiratory Cell and Molecular Biology|August 31, 2004
Acute allergen-induced airway remodeling in atopic asthmaSimon Phipps, Farid Benyahia, Tsan-Teng Ou, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteersAndrew Menzies-Gow, Sun Ying, Ian Sabroe, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2005
Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challengeYee Ean Ong, Andrew Menzies-Gow, Julia Barkans, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmaticsAndrew Menzies-Gow, Patrick Flood-Page, Roma Sehmi, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 4, 2008
Eosinophils: biological properties and role in health and diseaseSimon P Hogan, Helene F Rosenberg, Redwan Moqbel, et al.
The Journal of Clinical Investigation|October 3, 2003
Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmaticsPatrick Flood-Page, Andrew Menzies-Gow, Simon Phipps, et al.
The Journal of Allergy and Clinical Immunology|September 8, 2009
Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthmaHarsha H Kariyawasam, Sophie Pegorier, Julia Barkans, et al.
Immunology|July 23, 2003
Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammationRoma Sehmi, Sandra Dorman, Adrian Baatjes, et al.
The Journal of Allergy and Clinical Immunology|January 8, 2011
Development and preliminary clinical evaluation of a peptide immunotherapy vaccine for cat allergyMargitta Worm, Hae-Hyuk Lee, Jörg Kleine-Tebbe, et al.
Pageof 5